| Midwest Medical Associates, Llc | |
|
1116 Millis Ave Suite 101 Boonville IN 47601-2242 | |
| (812) 897-7383 | |
| (812) 897-7236 |
| Full Name | Midwest Medical Associates, Llc |
|---|---|
| Speciality | Family Medicine |
| Location | 1116 Millis Ave, Boonville, Indiana |
| Authorized Official Name and Position | Maria Rita Bolisay (PARTNER) |
| Authorized Official Contact | 8128977383 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Midwest Medical Associates, Llc 1116 Millis Ave Suite 101 Boonville IN 47601-2242 Ph: (812) 897-7383 | Midwest Medical Associates, Llc 1116 Millis Ave Suite 101 Boonville IN 47601-2242 Ph: (812) 897-7383 |
| NPI Number | 1033215645 |
|---|---|
| Provider Enumeration Date | 09/15/2006 |
| Last Update Date | 10/19/2007 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033215645 | NPI | - | NPPES |
| 200404200A | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 01047204 (Indiana) | Primary |
News Archive
Accretive Health, Inc., a provider of end-to-end revenue cycle management services for U.S. healthcare providers today announced the initial public offering of 10,000,000 shares of its common stock at a price to the public of $12.00 per share. Of the 10,000,000 shares being offered to the public, 6,666,667 shares are being offered by Accretive Health and 3,333,333 shares are being offered by selling stockholders.
RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today announced that Notices of Allowance were recently issued by the United States Patent Office (USPTO) on patent applications filed by Thermo Fisher Scientific Inc. and licensed to RXi Pharmaceuticals encompassing small interfering RNA (siRNA) sequences targeting superoxide dismutase (SOD1), Amyloid beta (A4) precursor protein (APP), interleukin-1 receptor-associated kinase 4 (IRAK4), hepatocyte growth factor receptor (MET protooncogene) and cyclin-dependent kinase (cdk) inhibitor p27 (also known as Kip1, CDKN1B).
The US Food and Drug Administration announced today that the drug ipilimumab has been approved for the treatment of patients with metastatic melanoma. It is the first drug ever shown to improve overall survival for patients with advanced melanoma.
A signaling molecule called interferon gamma could hold the key to understanding how harmful autoantibodies form in lupus patients. The finding could lead to new treatments for the chronic autoimmune disease, said researchers at Penn State College of Medicine.
Acerde, an innovative company specializing in the development of rotating anodes for X-ray tubes used in the medical imaging industry, today announced (i) the signature of a development contract with a major China-based player in medical imaging, (ii) its achievement of a number of industrial development milestones and (iii) the preparation of the company's next generation of highly innovative rotating anodes (which are now composite-based rather than graphite-based).
› Verified 2 days ago
Warrick County Health Department Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 107 W Locust St Ste 107, Boonville, IN 47601 Phone: 812-897-6105 Fax: 812-897-6410 | |
Deaconess Clinic, Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 930 W Main St, Boonville, IN 47601 Phone: 812-641-0088 Fax: 812-641-0092 | |
Syed A Ali Md Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1301 Millis Ave, Boonville, IN 47601 Phone: 812-897-4458 Fax: 812-897-5977 | |
Wilson Family Practice, Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 899 Aigner Dr, Boonville, IN 47601 Phone: 812-641-0262 Fax: 812-641-0557 | |
Deaconess Clinic I Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 3150 Warrick Dr, Boonville, IN 47601 Phone: 812-858-3355 Fax: 812-858-3350 |